FreeStyle Libre news in March 2026 centres on a key change for UK prescriptions and several international developments.
Abbott receives warning letter for FreeStyle Libre sensors from the FDA following an inspection. The letter focuses on problems with Abbott's tests and verification of accuracy of their CGMs.
A recent update to the Libre 3 app in the US now enables users to snap their meal to learn how their glucose will change. At the same time the app has made it possible to see levels on a smartwatch.
News that Abbott have agreed to collaborate with 4 pump providers for hybrid closed loop with their future combined glucose - ketone sensor.
News that Abbott and Dexcom have agreed not to sue each other for patents relating to their CGM tech for another 10 years.
Abbott announce Lingo to get full rollout in US in 2025.
Confirmation that Libre 2 Plus is to replace the Libre 2 sensor.
Tidepool announce they will integrate with Abbott's Freestyle Libre portfolio for seamless cloud-to-cloud data.
We welcome news that will sensors can remain in place for MRI and CT scans and X-rays.
